Pharmaceutical Technology on MSN21h
Atsena’s ATSN-201 gains FDA fast track status for XLRS treatment
The Phase I/II LIGHTHOUSE trial is assessing the safety and tolerability of the gene therapy in male subjects.
Healio17h
VIDEO: Dua’s layer has important implications in corneal pathologies
In this Healio Video Perspective from the ESCRS winter meeting, Harminder S. Dua, MD, PhD, professor of ophthalmology at the University of Nottingham, discusses the implications of Dua’s layer in ...